Judge Recommends Revoking Impax’s Registration

Law360, New York (May 1, 2007, 12:00 AM EDT) -- An administrative law judge has recommended that the U.S. Securities and Exchange Commission suspend or revoke the registration of Impax Laboratories on the grounds that the pharmaceutical company has not filed a financial report since 2004.

The judge, part of the internal adjudication mechanism of the SEC, issued the decision on April 30. Impax said that the company would appeal the ruling.

“The company will file a timely appeal to the Commission and hopes to persuade the Commission, based upon the evidence developed in a two-day...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.